Search Results

There are 11950 results for: content related to: The correlation structure of longitudinal measurements of vision in patients with macular degeneration

  1. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  2. Population Pharmacokinetics of Pegaptanib in Patients With Neovascular, Age-Related Macular Degeneration

    The Journal of Clinical Pharmacology

    Volume 52, Issue 8, August 2012, Pages: 1186–1199, Anthony S. Basile, Matt Hutmacher, Dana Nickens, Jace Nielsen, Ken Kowalski, Lloyd Whitfield, Oishi Masayo and Masami Nakane

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011412961

  3. You have free access to this content
    Cost-Effectiveness Model for Neovascular Age-Related Macular Degeneration: Comparing Early and Late Treatment with Pegaptanib Sodium Based on Visual Acuity

    Value in Health

    Volume 11, Issue 4, July/August 2008, Pages: 563–574, Jonathan C. Javitt, Gergana P. Zlateva, Stephanie R. Earnshaw, Andreas M. Pleil, Christopher N. Graham, Anita J. Brogan, Sonali N. Shah and Anthony P. Adamis

    Article first published online : 17 DEC 2007, DOI: 10.1111/j.1524-4733.2007.00283.x

  4. Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases

    Annals of the New York Academy of Sciences

    Volume 1082, Issue 1, October 2006, Pages: 151–171, EUGENE W.M. NG and ANTHONY P. ADAMIS

    Article first published online : 17 NOV 2006, DOI: 10.1196/annals.1348.062

  5. Anti-vascular endothelial growth factor for diabetic macular oedema

    Intervention Review

    The Cochrane Library

    Gianni Virgili, Mariacristina Parravano, Francesca Menchini and Jennifer R Evans

    Published Online : 24 OCT 2014, DOI: 10.1002/14651858.CD007419.pub4

  6. Assessing non-inferiority to an aggregate response with an application to development of pneumococcal conjugate vaccines

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 332–340, Yi Pan, Guanghan F. Liu and Michael J. Dallas

    Article first published online : 9 NOV 2010, DOI: 10.1002/pst.470

  7. Effects of unstratified and centre-stratified randomization in multi-centre clinical trials

    Pharmaceutical Statistics

    Volume 10, Issue 1, January/February 2011, Pages: 50–59, Vladimir V. Anisimov

    Article first published online : 28 JAN 2010, DOI: 10.1002/pst.412

  8. You have free access to this content
    Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage

    Acta Ophthalmologica

    Volume 88, Issue 5, August 2010, Pages: e170–e176, Sebastian Thaler, Michal Fiedorowicz, Tomasz J. Choragiewicz, Sylvia Bolz, Ayseguel Tura, Sigrid Henke-Fahle, Efdal Yoeruek, Eberhart Zrenner, Karl-Ulrich Bartz-Schmidt, Focke Ziemssen and Frank Schuettauf

    Article first published online : 14 MAY 2010, DOI: 10.1111/j.1755-3768.2010.01927.x

  9. Assessing departure from dose linearity under a repeated measures incomplete block design

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 357–362, Bin Cheng and Shein-Chung Chow

    Article first published online : 22 NOV 2010, DOI: 10.1002/pst.474

  10. An optimal adaptive design to address local regulations in global clinical trials

    Pharmaceutical Statistics

    Volume 9, Issue 3, July/September 2010, Pages: 179–189, Xiaolong Luo, Weichung Joe Shih, S. Peter Ouyang and Robert J. DeLap

    Article first published online : 22 SEP 2010, DOI: 10.1002/pst.456

  11. Assessing consistent treatment effect in a multi-regional clinical trial: a systematic review

    Pharmaceutical Statistics

    Volume 9, Issue 3, July/September 2010, Pages: 242–253, Joshua Chen, Hui Quan, Bruce Binkowitz, S. Peter Ouyang, Yoko Tanaka, Gang Li, Shailendra Menjoge and Ekopimo Ibia

    Article first published online : 14 MAY 2010, DOI: 10.1002/pst.438

  12. The impact of period effects on dose level contrasts in alternating cross-over designs for first-time-in-human studies

    Pharmaceutical Statistics

    Volume 10, Issue 1, January/February 2011, Pages: 45–49, Stephan Koehne-Voss, Heinz Schmidli, David M. Smith and Iris Pigeot

    Article first published online : 8 FEB 2010, DOI: 10.1002/pst.409

  13. A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 374–378, John W. Stevens

    Article first published online : 11 MAR 2011, DOI: 10.1002/pst.491

  14. You have free access to this content
    Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: A Prospective Study

    Acta Ophthalmologica

    Volume 90, Issue 3, May 2012, Pages: 254–258, Maria M. Knip and Juha Välimäki

    Article first published online : 30 APR 2010, DOI: 10.1111/j.1755-3768.2010.01904.x

  15. Comparison of several imputation methods for missing baseline data in propensity scores analysis of binary outcome

    Pharmaceutical Statistics

    Volume 9, Issue 4, October/December 2010, Pages: 269–279, Brenda J. Crowe, Ilya A. Lipkovich and Ouhong Wang

    Article first published online : 28 AUG 2009, DOI: 10.1002/pst.389

  16. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  17. You have free access to this content
    Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion

    Intervention Review

    The Cochrane Library

    Tasanee Braithwaite, Afshan A Nanji, Kristina Lindsley and Paul B Greenberg

    Published Online : 1 MAY 2014, DOI: 10.1002/14651858.CD007325.pub3

  18. Adapting by calibration the sample size of a phase III trial on the basis of phase II data

    Pharmaceutical Statistics

    Volume 10, Issue 2, March/April 2011, Pages: 89–95, Daniele De Martini

    Article first published online : 8 FEB 2010, DOI: 10.1002/pst.410

  19. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 347–356, Martin Jenkins, Andrew Stone and Christopher Jennison

    Article first published online : 8 DEC 2010, DOI: 10.1002/pst.472

  20. Investigating the assumption of homogeneity of treatment effects in clinical studies with application to meta-analysis

    Pharmaceutical Statistics

    Volume 11, Issue 1, January/February 2012, Pages: 49–56, Steven A. Julious and Anne Whitehead

    Article first published online : 2 DEC 2011, DOI: 10.1002/pst.494